gemcitabine has been researched along with Dysphagia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bottomley, A; Coens, C; Ediebah, DE; Flechtner, H; Gotay, C; Greimel, E; King, MT; Quinten, C; Reeve, BB; Ringash, J; Schmucker von Koch, J; Smit, EF; Taphoorn, MJ; Weis, J; Zikos, E | 1 |
| Aguilar-Ponce, JL; Alvarez-Avitia, MA; Arrieta, O; Castillo-Hernández, C; Cruz López, JC; De la Garza-Salazar, J; González-Ramírez, I; Granados-García, M; Lara-Cruz, G; Maldonado-Magos, F; Martinez-Juárez, I; Medina-Santillan, R | 1 |
| Balm, AJ; Damen, E; Eisbruch, A; Marsh, R; Pameijer, FA; Rasch, C; Schwartz, M; Van As, CJ; Vineberg, K | 1 |
| Robbins, KT | 1 |
| Bradford, CR; Chepeha, DB; Dawson, LA; Eisbruch, A; Haxer, MJ; Hogikyan, ND; Lyden, T; Miller, AE; Teknos, TN; Terrell, JE; Wolf, GT | 1 |
2 trial(s) available for gemcitabine and Dysphagia
| Article | Year |
|---|---|
Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Deglutition; Deglutition Disorders; Deoxycytidine; Gemcitabine; Head and Neck Neoplasms; Humans; Hypopharynx; Image Processing, Computer-Assisted; Palatine Tonsil; Pharyngeal Muscles; Pneumonia, Aspiration; Prospective Studies; Radiotherapy, Conformal; Tongue | 2004 |
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer.
Topics: Combined Modality Therapy; Deglutition; Deglutition Disorders; Deoxycytidine; Fluoroscopy; Gemcitabine; Head and Neck Neoplasms; Humans; Pneumonia, Aspiration; Prospective Studies; Radiation-Sensitizing Agents | 2002 |
3 other study(ies) available for gemcitabine and Dysphagia
| Article | Year |
|---|---|
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Deglutition Disorders; Deoxycytidine; Gemcitabine; Humans; Interpersonal Relations; Lung Neoplasms; Multicenter Studies as Topic; Nausea; Paclitaxel; Pain; Palliative Care; Prognosis; Proportional Hazards Models; Quality of Life; Randomized Controlled Trials as Topic; Risk; Severity of Illness Index; Surveys and Questionnaires; Survival Analysis | 2014 |
Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deglutition Disorders; Deoxycytidine; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Leukopenia; Male; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy Dosage; Remission Induction; Safety; Stomatitis; Survival Rate; Treatment Outcome; Xerostomia | 2013 |
Barriers to winning the battle with head-and-neck cancer.
Topics: Clinical Trials, Phase I as Topic; Deglutition; Deglutition Disorders; Deoxycytidine; Gemcitabine; Head and Neck Neoplasms; Humans; Radiation-Sensitizing Agents | 2002 |